Back to Results
First PageMeta Content
Orphan drugs / Organofluorides / Angiogenesis inhibitors / Pyridines / Macrolides / Sunitinib / Renal cell carcinoma / Bevacizumab / Sorafenib / Chemistry / Organic chemistry / Medicine


1st line treatment: what has changed in the last 2 years? 10th European International Kidney Cancer Symposium Lyon April 2015
Add to Reading List

Document Date: 2015-05-04 13:05:49

Open Document

File Size: 975,33 KB

Share Result on Facebook

City

Budapest / /

Company

AEs / R A N D O M I S A T / McDermott / /

Event

FDA Phase / /

Facility

Martin Gore PhD FRCP Royal Marsden Hospital Institute of Cancer Research London What / Martin Gore PhD FRCP Royal Marsden Hospital Institute of Cancer Research London Targeted Agents / Martin Gore PhD FRCP Royal Marsden Hospital Institute of Cancer Research London Renal Cell Carcinoma BMS / /

IndustryTerm

treatment algorithm / /

Organization

Martin Gore PhD FRCP Royal Marsden Hospital Institute of Cancer Research London Renal Cell Carcinoma BMS / Martin Gore PhD FRCP Royal Marsden Hospital Institute of Cancer Research London Targeted Agents for mRCC RCT / Martin Gore PhD FRCP Royal Marsden Hospital Institute of Cancer Research London What / /

Person

Ann Oncol / /

Product

NCT00465179 / Sunitinib / /

Technology

treatment algorithm / /

SocialTag